San Diego, CA, United States of America

Jason A Kahana

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: January Therapeutics, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason A Kahana. Retrieved from https://idiyas.com/inventor/jason-a-kahana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jason A. Kahana: Innovator in Nanoparticle Compositions

Introduction

Jason A. Kahana is a notable inventor based in San Diego, California. He has made significant contributions to the field of nanoparticle compositions, particularly in the development of formulations that incorporate organophosphate compounds. His work is essential in advancing pharmaceutical applications.

Latest Patents

Jason A. Kahana holds 1 patent for his innovative work on nanoparticle compositions. The patent details compositions that comprise an organophosphate compound along with pharmaceutically acceptable carriers. This invention has the potential to enhance drug delivery systems and improve therapeutic outcomes.

Career Highlights

Kahana is currently associated with January Therapeutics, Inc., where he continues to push the boundaries of research and development in the pharmaceutical industry. His expertise in nanoparticle technology positions him as a valuable asset to the company and the broader scientific community.

Collaborations

Throughout his career, Jason has collaborated with esteemed colleagues, including Raj Raheja and Robin M. Jackman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jason A. Kahana's contributions to nanoparticle compositions exemplify the impact of innovative thinking in the pharmaceutical field. His work not only advances scientific knowledge but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…